Intelligence Driven Advisers, LLC Novo Nordisk A S Transaction History

Intelligence Driven Advisers, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$102.11 - $135.92 $213,920 - $284,752	-2,095 Reduced 44.9%	2,571 $330,000
Q4 2023 Feb 06, 2024	BUY	$87.78 - $105.45 $66,888 - $80,352	762 Added 19.52%	4,666 $482,000
Q3 2023 Nov 07, 2023	BUY	$90.94 - $199.54 $198,158 - $434,797	2,179 Added 126.32%	3,904 $355,000
Q2 2023 Jul 18, 2023	SELL	$155.98 - $172.65 $1,247 - $1,381	-8 Reduced 0.46%	1,725 $279,000
Q1 2023 May 11, 2023	BUY	$132.34 - $159.14 $397 - $477	3 Added 0.17%	1,733 $275,000
Q4 2022 Jan 23, 2023	SELL	$102.55 - $135.33 $19,484 - $25,712	-190 Reduced 9.9%	1,730 $240,000
Q3 2022 Oct 21, 2022	BUY	$95.28 - $116.93 $182,937 - $224,505	1,920 New	1,920 $203,000
Q4 2021 Jan 19, 2022	BUY	$95.88 - $117.08 $237,398 - $289,890	2,476 New	2,476 $251,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Intelligence Driven Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Intelligence Driven Advisers, LLC with notifications on news.